BRCA1, BRCA2 and your 23andMe raw data: what it can (and can't) tell you

Understanding the limits · Updated June 2026

23andMe & raw DNA

What are BRCA1 and BRCA2?

BRCA1 and BRCA2 are tumor-suppressor genes. In plain terms, they are part of the cell's repair crew: they help fix a particular kind of damage to DNA — double-strand breaks — that happens naturally as cells divide over a lifetime. When that repair machinery works, damaged cells are either mended or safely retired. When it's impaired, errors can accumulate, and the risk that a cell tips over into cancer goes up.

Everyone inherits two copies of each gene, one from each parent. A pathogenic (harmful) variant in one copy doesn't cause cancer on its own, but it weakens that DNA-repair safety net across the tissues most sensitive to it. Over a lifetime, that meaningfully raises the risk of hereditary breast and ovarian cancer. Pathogenic BRCA variants are also associated, to varying degrees, with prostate cancer, pancreatic cancer, and male breast cancer. The exact level of risk depends on the specific variant, which gene it's in, and your personal and family history — which is one reason these results are interpreted by specialists rather than read off a chart.

Because these variants are inherited, they run in families. A confirmed finding in one relative can be relevant to parents, siblings, and children, who each have a chance of carrying the same variant. That is also why a genuine result — a clinically confirmed one — is rarely a private matter: it opens a conversation with the whole family.

This is exactly why people search their DNA data for BRCA markers. The stakes feel high, the topic is frightening, and a downloaded file seems to promise a fast, private answer. But hereditary cancer risk is one of the areas where consumer raw data is most easily misread, and where a misread can do real harm.

How people look for BRCA markers in 23andMe raw data

After downloading their 23andMe raw data file, people open it and search for specific rsid rows tied to BRCA1 and BRCA2, then check the genotype letters at those positions. Some third-party tools do this automatically, and you can also explore your raw data privately in your browser to see which of these positions your file even contains, without uploading it anywhere. On the surface it looks definitive — a marker is either present or absent. In reality, the picture is far narrower than it appears.

The critical limitation: 23andMe tests only a few BRCA variants

This is the heart of the matter, and it's worth stating as plainly as possible. 23andMe uses a genotyping array — a chip that reads specific, pre-selected positions in your genome. It does not sequence the whole BRCA1 and BRCA2 genes. It checks only the exact spots the chip was designed to check. Historically, its BRCA-related testing has focused on just three founder mutations — the three most common in people of Ashkenazi Jewish descent.

BRCA1 and BRCA2, however, are large genes with thousands of known pathogenic variants scattered across them. The overwhelming majority of those are not on the chip at all. If you carry one of them — and most people who carry a pathogenic BRCA variant carry one that 23andMe does not test — it simply will not show up in your raw data. Not as a warning, not as a flag, not as anything. The file cannot report what it never measured. This isn't a flaw in your particular download; it's a fundamental property of how array-based consumer testing works.

Think of it like checking three doors in a very large building and finding them locked. That tells you nothing about the hundreds of other doors you never walked past. A clean result on those three doors is not a clean result on the building.

Two things follow from this, and both matter. A negative result is not safety — it's silence about almost everything. And a positive result is not a diagnosis either: consumer raw data is not clinically validated, false positives happen, and a hit at one of those three positions needs to be confirmed with clinical-grade testing before it means anything for your health.

Why this matters for your health decisions

The danger isn't the data itself — it's the false sense of safety a "negative" can create. Picture someone whose mother and aunt both had breast cancer young. They open their raw data, search for BRCA, see nothing flagged, and quietly feel relieved. They skip the appointment they were going to make. But their family history hasn't changed, and the test they just ran couldn't see the variants most likely to be responsible. That relief is exactly the outcome to avoid, because it can talk someone out of the testing that would actually answer their question.

Family history matters regardless of what the chip shows. A negative raw-data result does not lower the significance of a strong family history, and a strong family history is a reason to seek proper evaluation even if every consumer test you've ever run came back clean. The two pieces of information live on different levels: one is a narrow, unvalidated snapshot; the other is a genuine clinical signal.

Consumer raw data is a useful window into well-studied, common markers, and there's nothing wrong with curiosity. But for something as consequential as hereditary cancer risk, it is the wrong tool to lean on for a final answer — in either direction.

Family-history red flags worth raising with a doctor

You don't need a positive genetic result to justify a conversation about hereditary cancer risk. Any of the following are reasonable prompts to ask your doctor whether genetic counseling makes sense for you:

• Breast cancer diagnosed before age 50, or in more than one close relative
• Ovarian cancer at any age, on either side of the family
• Male breast cancer in any relative
• Breast and ovarian cancer in the same person or the same side of the family
• Several relatives with breast, ovarian, prostate, or pancreatic cancer
• A known BRCA1 or BRCA2 variant already identified in a family member
• Ashkenazi Jewish ancestry combined with a family history of these cancers

None of these mean you carry a variant, and having none of them doesn't mean you're risk-free. They're simply the patterns that make professional evaluation worthwhile. The decision about who should be tested belongs to you and a qualified clinician — not to a raw-data file.

What to do instead: clinical testing and genetic counseling

If you have a personal or family history of breast, ovarian, prostate, or pancreatic cancer — or you found a BRCA marker in your raw data, or you're simply worried — the responsible path is clinical-grade genetic testing ordered through a healthcare provider, paired with genetic counseling. Clinical testing sequences the BRCA genes far more comprehensively than a consumer array, and can look at other hereditary-cancer genes too. A genetic counselor is the specialist who ties it all together: they take a detailed family history, decide what testing (if any) fits your situation, interpret the results honestly — including the uncertain ones — and help you think through what to do next. They also help you weigh whether you want to know, and how a result might affect relatives.

Crucially, if you did find something in your raw data, bring it to them rather than acting on it. A positive raw-data result must be confirmed clinically before any medical decision. Consumer files can carry errors, and even a real variant needs to be placed in context before it means anything for your care. Do not substitute 23andMe raw data for this process, and don't let it end the process either.

If a variant is confirmed: there are real options

Learning that you carry a confirmed pathogenic BRCA variant is heavy news, but it is not a verdict, and it is not the end of the story. Elevated risk is not certainty, and confirmed carriers have meaningful, evidence-based options — which is a large part of why this information can be worth having when it's handled properly.

In general terms, and to be decided with a genetics and medical team rather than from any article: confirmed carriers typically discuss enhanced screening (earlier and more frequent monitoring, sometimes with additional imaging), risk-reducing strategies, and cascade testing — offering relatives the chance to find out whether they carry the same variant. Which of these fit depends heavily on the specific variant, your age and health, and your own preferences. These are deeply personal choices, and a genetic counselor and your doctors are the right people to walk through them with you. The point worth holding onto is that a confirmed result opens doors to action, not just anxiety.

The emotional weight of this — and going gently with it

It's worth naming that this is not a neutral topic. Searching your own DNA for a cancer marker can stir up real fear, and finding something — or convincing yourself you've found something — in a raw-data file, alone, late at night, is a genuinely hard experience. Consumer data makes it easy to spiral in either direction: unearned relief from a negative, or unnecessary panic from an unconfirmed positive.

If that's where you are, the kindest and most useful thing you can do is slow down and bring a real person into it. A genetic counselor or your doctor can tell you what a result actually means, whether it needs confirming, and what your options are — and that context tends to replace free-floating dread with something you can act on. You do not have to interpret this on your own, and you shouldn't have to.

Can you still learn anything useful from your raw data?

Yes — with the right framing, and within firm limits. Your raw file can show you which specific positions a consumer test did and didn't cover, sit alongside other well-studied health and trait markers, and serve as a concrete prompt to start a conversation with a clinician. Treated as a starting point and an educational tool — never as a diagnostic verdict — it has a place.

This is the spirit in which Quanome handles genetic data. It imports your 23andMe, Ancestry, or whole-genome file and parses it locally on your device, so nothing is uploaded, and it's honest about what a consumer file can and can't tell you rather than dressing narrow markers up as answers. It is built for understanding and education, and it does not replace clinical-grade genetic testing or genetic counseling.

For the bigger picture of what raw data does and doesn't include, see our guide to 23andMe raw data and our overview of what 23andMe raw data reveals about health. If you're exploring other single-gene results, our write-up on APOE4 in your 23andMe raw data walks through similar limits with another serious, well-known marker. And whatever you find, remember the one rule that matters most here: for hereditary cancer risk, the raw file is where curiosity starts — a genetic counselor and clinical testing are where answers come from.

Frequently asked questions

Does 23andMe test for all BRCA1 and BRCA2 variants?

No. 23andMe tests only a small, fixed set of BRCA variants — historically three founder mutations most common in people of Ashkenazi Jewish descent. Thousands of other pathogenic BRCA variants are not tested, so they will not appear in your raw data.

Is a negative 23andMe BRCA result reassuring?

No. A negative or absent BRCA result in your 23andMe raw data only means the few variants 23andMe checks were not detected. It does not rule out the thousands of other pathogenic BRCA variants and should not be treated as reassurance. If you are concerned, get clinical-grade testing and genetic counseling.

How should I actually find out my BRCA cancer risk?

Through clinical-grade BRCA testing ordered by a healthcare provider, combined with genetic counseling. This is far more comprehensive than consumer raw data and is interpreted alongside your personal and family history.

Does a negative 23andMe result mean I'm in the clear?

No — clearly not. A negative or absent BRCA result on 23andMe means only that the handful of variants it checks were not found in your file. It cannot rule out the thousands of BRCA variants it never tested, and it says nothing about other hereditary-cancer genes. It is not an all-clear and should never be treated as one. If you have a personal or family history of cancer, talk to a genetic counselor regardless of what your raw data shows.

I found a BRCA variant in my raw data — what should I do?

Do not act on it or make any decisions based on the raw data alone. Consumer raw data is not clinically validated and can contain errors. Take the result to a healthcare provider or genetic counselor, who can arrange clinical-grade confirmatory testing. A positive raw-data result must always be confirmed clinically before any medical decision.

What family history is worth raising with a doctor?

Breast cancer (especially before age 50 or in more than one relative), ovarian cancer at any age, male breast cancer, several relatives with related cancers on the same side of the family, Ashkenazi Jewish ancestry with a family cancer history, or a known BRCA variant in the family. Any of these are reasons to ask about genetic counseling — independent of what any consumer test shows.

Does 23andMe test BRCA the same way for everyone?

The array checks the same fixed set of positions for everyone, but the founder variants it focuses on are most informative for people of Ashkenazi Jewish descent. For most people and most populations, the test covers only a tiny fraction of the pathogenic variants that could matter, so its limits apply broadly.

What do confirmed BRCA carriers do next?

That is a decision made with a genetics team and clinicians, not something to plan from raw data. Confirmed carriers typically discuss enhanced screening, risk-reducing options, and cascade testing for relatives. These choices are personal and depend on the specific variant, your health, and your family history — a genetic counselor guides them.